REQUEST A DEMO
Total
USD $0.00
Search more companies

Tradupharma S.A. (Ecuador)

Main Activities: Language Schools
Secondary Activities: Management Consulting Services | Administrative Management and General Management Consulting Services | Computer Training
Full name: Tradupharma S.A. Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Tradupharma S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the Language Schools industry. The company was established on January 31, 2020. The total number of employees is currently 4 (2024). There was a net sales revenue increase of 232.36% reported in Tradupharma S.A.’s latest financial highlights for 2024. Its total assets decreased by 6.08% over the same period. The net profit margin of Tradupharma S.A. decreased by 8% in 2024.

Headquarters
Av Quito 806, Induauto Bldg. , Floor 12
Guayaquil; Guayas;

Contact Details: Purchase the Tradupharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Tradupharma S.A. report to view the information.
Registered Capital:
Purchase the Tradupharma S.A. report to view the information.
Financial Auditors:
Purchase the Tradupharma S.A. report to view the information.
Incorporation Date:
January 31, 2020
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.88%
Purchase this report to view the information.
0.12%
Company Performance
Financial values in the chart are available after Tradupharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
232.36%
Total operating revenue
232.36%
Operating profit (EBIT)
-26.37%
EBITDA
-26.37%
Net Profit (Loss) for the Period
-26.37%
Total Assets
-6.08%
Total Equity
-6.08%
Operating Profit Margin (ROS)
-8%
Net Profit Margin
-8%
Return on Equity (ROE)
-4.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?